Clinical Trial Update: ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial examining the use of indocyanine green fluorescence to detect sentinel lymph nodes in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Indocyanine Green (ICG) (indocyanine green)

Snippet

Sponsor: Pulsion Medical Systems SE | Conditions: Malignant Neoplasm of Breast | Phase 2 | Status: UNKNOWN